Clinical trials
Observational Communicable Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 11 |
| Unknown status | 4 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Emory University | 2 |
| InBios International, Inc. | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| University of North Carolina, Chapel Hill | 2 |
| iSpecimen Inc | 2 |
| Anova Enterprises, Inc | 1 |
| Audubon Bioscience | 1 |
| BioFire Diagnostics, LLC | 1 |
| Brooklyn Clinical Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communicable Diseases | 45 |
| COVID-19 | 5 |
| Neoplasms | 5 |
| Autoimmune Diseases | 4 |
| Skin Diseases | 3 |
| Arthritis | 2 |
| Chronic Disease | 2 |
| Coronavirus Infections | 2 |
| Digestive System Diseases | 2 |
| Eye Diseases | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.